Poppy Koronka, a health correspondent for The Times, and Eleanor Hayward, the health editor, delve into the controversial rise of weight loss medications like Ozempic. They discuss how social media influencers market these drugs, often targeting vulnerable audiences. The duo reveals ethical concerns surrounding unregulated prescriptions and the serious health risks faced by those misusing these medications. The podcast highlights the urgent need for regulatory interventions to tackle the alarming accessibility of these drugs for individuals who may not even need them.

It's one of the world's biggest killers but cancer is usually more associated with people in the later stages of life. While that's still largely the case, increasing numbers of younger people seem to be getting the disease. So what could be behind the rise?This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: http://thetimes.com/thestoryGuests:Molly Guinness, Times Radio Executive Producer.Eleanor Hayward, Times Health Editor.Host: Luke Jones.Clips: BBC; You, Me and the Big C.Get in touch: storiesofourtimes@thetimes.co.ukFind out more about our bonus series for Times subscribers: 'Inside the newsroom' Hosted on Acast. See acast.com/privacy for more information.